Literature DB >> 24969615

Multi-resistant aspergillosis due to cryptic species.

Susan Julie Howard1.   

Abstract

Reports of cryptic species causing aspergillosis in humans are increasing in the literature. Cryptic species are defined as those which are morphologically indistinguishable, although their identifications can be confirmed using molecular or other techniques which continue to become more widely available in the clinical setting. Antifungal resistance has often been noted in these cases, and indeed there does appear to be a higher prevalence of reduced susceptibility in cryptic species. Many of these observations are published as individual case reports or as a small component of larger data sets, making it challenging to review and compare the data fully. This review article seeks to describe the susceptibility trends and key learning outcomes of specific cases of infections caused by cryptic species, including Aspergillus alliaceus, Aspergillus calidoustus, Aspergillus felis, Aspergillus lentulus, Aspergillus tubingensis, Aspergillus viridinutans and Neosartorya pseudofischeri. These reports highlight the clinical need for full accurate identification and susceptibility testing to guide patient care.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24969615     DOI: 10.1007/s11046-014-9774-0

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  27 in total

1.  Emergence of Aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis.

Authors:  Adrian Egli; Jeff Fuller; Atul Humar; Dale Lien; Justin Weinkauf; Roland Nador; Ali Kapasi; Deepali Kumar
Journal:  Transplantation       Date:  2012-08-27       Impact factor: 4.939

2.  Polyphasic characterization of fungal isolates from a published case of invasive aspergillosis reveals misidentification of Aspergillus felis as Aspergillus viridinutans.

Authors:  Sergio Álvarez-Pérez; Emilia Mellado; David Serrano; José L Blanco; Marta E Garcia; Mi Kwon; Patricia Muñoz; Manuel Cuenca-Estrella; Emilio Bouza; Teresa Peláez
Journal:  J Med Microbiol       Date:  2014-01-27       Impact factor: 2.472

Review 3.  Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection.

Authors:  Susan Julie Howard; Maiken Cavling Arendrup
Journal:  Med Mycol       Date:  2010-08-26       Impact factor: 4.076

4.  Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus.

Authors:  S Arunmozhi Balajee; Jennifer L Gribskov; Edward Hanley; David Nickle; Kieren A Marr
Journal:  Eukaryot Cell       Date:  2005-03

5.  Isolation of Neosartorya pseudofischeri from blood: first hint of pulmonary Aspergillosis.

Authors:  H Järv; J Lehtmaa; R C Summerbell; E S Hoekstra; R A Samson; P Naaber
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

6.  Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri.

Authors:  Laura Alcazar-Fuoli; Emilia Mellado; Ana Alastruey-Izquierdo; Manuel Cuenca-Estrella; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2009-07-27       Impact factor: 5.191

7.  Nonsporulating clinical isolate identified as Petromyces alliaceus (anamorph Aspergillus alliaceus) by morphological and sequence-based methods.

Authors:  S Arunmozhi Balajee; Mark D Lindsley; Naureen Iqbal; James Ito; Peter G Pappas; Mary E Brandt
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

8.  Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study).

Authors:  A Alastruey-Izquierdo; E Mellado; T Peláez; J Pemán; S Zapico; M Alvarez; J L Rodríguez-Tudela; M Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2013-05-13       Impact factor: 5.191

9.  Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.

Authors:  Susan J Howard; Dasa Cerar; Michael J Anderson; Ahmed Albarrag; Matthew C Fisher; Alessandro C Pasqualotto; Michel Laverdiere; Maiken C Arendrup; David S Perlin; David W Denning
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

10.  Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.

Authors:  Eveline Snelders; Henrich A L van der Lee; Judith Kuijpers; Anthonius J M M Rijs; János Varga; Robert A Samson; Emilia Mellado; A Rogier T Donders; Willem J G Melchers; Paul E Verweij
Journal:  PLoS Med       Date:  2008-11-11       Impact factor: 11.069

View more
  14 in total

Review 1.  The Emerging Threat of Antifungal Resistance in Transplant Infectious Diseases.

Authors:  Ilan S Schwartz; Thomas F Patterson
Journal:  Curr Infect Dis Rep       Date:  2018-02-05       Impact factor: 3.725

2.  Assessment of multi-contaminant exposure in a cancer treatment center: a 2-year monitoring of molds, mycotoxins, endotoxins, and glucans in bioaerosols.

Authors:  Natacha Heutte; Véronique André; Catherine Dubos Arvis; Valérie Bouchart; Françoise Lemarié; Patrick Legendre; Edwige Votier; Marie-Yolande Louis; Stéphane Madelaine; Virginie Séguin; Stéphanie Gente; Philippe Vérité; David Garon
Journal:  Environ Monit Assess       Date:  2016-12-23       Impact factor: 2.513

3.  Advances against aspergillosis: biology, host response, diagnosis and treatment.

Authors:  David S Askew; Dimitrios P Kontoyiannis; Karl V Clemons
Journal:  Mycopathologia       Date:  2014-10-07       Impact factor: 2.574

4.  Antifungal Susceptibility of the Aspergillus viridinutans Complex: Comparison of Two In Vitro Methods.

Authors:  Pavlina Lyskova; Vit Hubka; Lucie Svobodova; Vanessa Barrs; Navneet K Dhand; Takashi Yaguchi; Tetsuhiro Matsuzawa; Yoshikazu Horie; Miroslav Kolarik; Radim Dobias; Petr Hamal
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

5.  In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.

Authors:  Hamid Badali; Hamed Fakhim; Fereshteh Zarei; Mojtaba Nabili; Afsane Vaezi; Nafiseh Poorzad; Somayeh Dolatabadi; Hossein Mirhendi
Journal:  Mycopathologia       Date:  2015-11-28       Impact factor: 2.574

6.  Vitek® MS v3.0 System in the Identification of Filamentous Fungi.

Authors:  Dolores Pinheiro; Carolina Monteiro; Miguel A Faria; Eugénia Pinto
Journal:  Mycopathologia       Date:  2019-09-10       Impact factor: 2.574

7.  Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 2013.

Authors:  Maxime Parent-Michaud; Philippe J Dufresne; Eric Fournier; Benjamin Folch; Christine Martineau; Sandrine Moreira; Nicolas Doucet; Louis De Repentigny; Simon F Dufresne
Journal:  J Antimicrob Chemother       Date:  2020-04-01       Impact factor: 5.790

Review 8.  Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Aspergillus Fungi.

Authors:  Daisuke Hagiwara; Akira Watanabe; Katsuhiko Kamei; Gustavo H Goldman
Journal:  Front Microbiol       Date:  2016-09-21       Impact factor: 5.640

Review 9.  Extrolites of Aspergillus fumigatus and Other Pathogenic Species in Aspergillus Section Fumigati.

Authors:  Jens C Frisvad; Thomas O Larsen
Journal:  Front Microbiol       Date:  2016-01-07       Impact factor: 5.640

10.  Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases: Comparison between Aspergillus fumigatus and non-fumigatus Aspergillus species.

Authors:  Sung-Yeon Cho; Dong-Gun Lee; Jae-Ki Choi; Hyo-Jin Lee; Si-Hyun Kim; Sun Hee Park; Su-Mi Choi; Jung-Hyun Choi; Jin-Hong Yoo; Yeon-Joon Park; Jong-Wook Lee
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.